These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 5880954)

  • 1. [Acetylation of p-aminosalicylic acid and isoniazid in the perfused liver as a competitive enzymatic process].
    Wagner J; Dolezal V
    Acta Univ Carol Med (Praha); 1965; ():Suppl 21:165+. PubMed ID: 5880954
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acetylation phenotype and biotransformation of various drugs].
    Grygorowicz J; Januszko J
    Wiad Lek; 1987 Mar; 40(5):319-23. PubMed ID: 3303698
    [No Abstract]   [Full Text] [Related]  

  • 3. Partial purification and properties of the isoniazid transacetylase in human liver. Its relationship to the acetylation of p-aminosalicylic acid.
    Jennne JW
    J Clin Invest; 1965 Dec; 44(12):1992-2002. PubMed ID: 5851956
    [No Abstract]   [Full Text] [Related]  

  • 4. [Enzymatic transformation of isonicotinic acid hydrazide--a pharmacogenetic problem].
    Goedde HW; Schloot W; Valesky A
    Arzneimittelforschung; 1966 Aug; 16(8):1030-4. PubMed ID: 4969359
    [No Abstract]   [Full Text] [Related]  

  • 5. [Functional state of the liver and the metabolism of isoniazid and PASA in adolescents with intrathoracic tuberculosis].
    Tytor IaN
    Probl Tuberk; 1976 Jul; (7):29-32. PubMed ID: 959195
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.
    Lehmann J
    Scand J Respir Dis; 1969; 50(3):169-85. PubMed ID: 5195904
    [No Abstract]   [Full Text] [Related]  

  • 7. Inactivation of isoniazid (INH) in Swedish tuberculous patients before and during treatment with para-aminosalicylic acid (PAS).
    Hanngren A; Borgå O; Sjöqvist F
    Scand J Respir Dis; 1970; 51(1):61-9. PubMed ID: 5456864
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetics of isoniazid, PAS, and cycloserin in acute and chronic alcoholic intoxication (experimental study)].
    Ortenberg ZA
    Probl Tuberk; 1978 Sep; (9):60-4. PubMed ID: 568263
    [No Abstract]   [Full Text] [Related]  

  • 9. [Administration by slow phleboclysis of isoniazid and para-aminosalicylic acid in the treatment of tuberculosis. Therapeutic effects and blood levels of the drug].
    Mariani B; Bisetti A; Monzali G
    G Ital Mal Torace; 1967; 21(2):81-92. PubMed ID: 5602966
    [No Abstract]   [Full Text] [Related]  

  • 10. A slow-release preparation of isoniazid: pharmacological aspects.
    Ellard GA
    Bull Int Union Tuberc; 1976; 51(1):144-54. PubMed ID: 1030275
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isoniazid and PAS metabolism and bacteriostatic activity of blood in adolescents with intrathoracic tuberculosis].
    Tytor IaM
    Probl Tuberk; 1975; (7):51-4. PubMed ID: 1082592
    [No Abstract]   [Full Text] [Related]  

  • 12. Polymorphic acetylation of drugs in rabbits.
    Gordon GR; Shafizadeh AG; Peters JH
    Xenobiotica; 1973 Mar; 3(3):133-50. PubMed ID: 4729680
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacogenetic and interaction-model with some usual antitubercular agents].
    Hanngren A; Boman G; Borgå O; Malmborg AS; Sjöqvist F
    Nord Med; 1970 Sep; 84(38):1204. PubMed ID: 5469274
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concentration of tubazid, PAS and streptomycin in the blood and lung tissue in standard and intravenous administration].
    Kovalenko NN
    Vrach Delo; 1969 Oct; 10():134-5. PubMed ID: 5366785
    [No Abstract]   [Full Text] [Related]  

  • 15. [Peculiarities of PAS and tubazid metabolism in tuberculous patients treated with nerobol and ATP].
    Sabula MM
    Probl Tuberk; 1972; 50(1):47-50. PubMed ID: 5010779
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay of antituberculosis drugs in tuberculous patients.
    Kent DC
    Dis Chest; 1966 Jun; 49(6):595-9. PubMed ID: 5935729
    [No Abstract]   [Full Text] [Related]  

  • 17. Kinetic characteristics of the acetylation of isoniazid and p-aminosalicylic acid by a liver-enzyme preparation.
    JENNE JW; BOYER PD
    Biochim Biophys Acta; 1962 Nov; 65():121-7. PubMed ID: 13957595
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of D-glucose and p-aminosalicylic acid on the metabolism of isoniazid.
    Peters JH; Gill M; Hayes VE
    Arch Int Pharmacodyn Ther; 1966 Feb; 159(2):340-52. PubMed ID: 5916739
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and properties of N-acetyltransferase from mammalian liver.
    Weber WW; Cohen SN; Steinberg MS
    Ann N Y Acad Sci; 1968 Jul; 151(2):734-41. PubMed ID: 4984197
    [No Abstract]   [Full Text] [Related]  

  • 20. Modification by para-aminosalicylic acid and sulfamethazine of the isoniazid inactivation in man.
    Tiitinen H
    Scand J Respir Dis; 1969; 50(4):281-90. PubMed ID: 5380785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.